According to FDA communications, the agency has distinguished between mass-marketed compounded products and patient-specific compounding performed under Section 503A of the FD&C Act, which may remain permissible in narrow circumstances where a patient's medical needs cannot be met by an FDA-approved drug
Abou-Khalil, R., Andary, J., & El-Hayek, E
Those same label references describe sterile water as a single-entry product
How can both be #1
The double protease approach substantially increased protein sequence coverage
Lifeforce requires that you must be over 18 years old, and you cannot have type 1 diabetes, poorly controlled diabetes, an eating disorder, a history of pancreatitis, or risk for medullary thyroid cancer, among other conditions that your Lifeforce clinician will review with you